Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vaxart
Biotech
Vaxart seeks answers as BARDA vaccine funding dries up again
Vaxart is actively seeking more information about why it was told to stop work under a federally funded COVID-19 vaccine contract.
Nick Paul Taylor
Aug 12, 2025 5:08am
HHS lifts stop work order on Vaxart's COVID-19 trial
Apr 28, 2025 12:48pm
HHS delivers stop work order to Atlanta biotech, pulls funding
Apr 16, 2025 11:02am
Vaxart lays off staffers after HHS demands halt to vaccine trial
Mar 21, 2025 8:36am
Biopharma largely unfazed by security concerns for JPM25
Jan 17, 2025 11:10am
JPM25, Day 2: Pharma should 'run towards' vaccine conversations
Jan 14, 2025 11:30am
